Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Benohanian A. L’hyperhidrose palmaire et plantaire. View at Publisher | View at Google Scholar

• Benohanian A. L’hyperhidrose focale: choisir l’approche thérapeutique.

  View at Publisher | View at Google Scholar

• Benohanian A. L’hyperhidrose palmoplantaire.

  View at Publisher | View at Google Scholar

• Bärnighausen T, Bloom DE, Canning D, Friedman A, Levine OS, et al. (2011) Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine 29: 2371-2380.

  View at Publisher | View at Google Scholar

• Méndez ED (2013) Actividad bacteriostática y bactericida de antibióticos betalactámicos y glucopéptidos frente a cepas de Staphylococcus aureus de importancia clínica. Caracterización genotípica de aislamientos tolerante (Doctoral dissertation).

  View at Publisher | View at Google Scholar

• Patel MI, Makhija SJ (2012) Toxicity assessment of Linezolid and the beneficial effects of human erythropoietin in mice. European Journal of Experimental Biology 2: 2172-2181.

  View at Publisher | View at Google Scholar

• Oh SH, Kim J, Baek SY, Chae SE, Park HS, et al. (2017) In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria. Molecules 22: 394.

  View at Publisher | View at Google Scholar
• Barrios V and Escobar C, 2008. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Expert opinion on pharmacotherapy, 9(1), pp.129-136. View at Publisher | View at Google Scholar | View at Indexing
• Barrios V, Coca A, Escobar C, Enrique R and Rincón LM, 2012. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice. Expert review of cardiovascular therapy, 10(2), pp.159-166. View at Publisher | View at Google Scholar | View at Indexing
• Barrios V and Escobar C, 2010. Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension–update on clinical utility. Integrated blood pressure control, 3, p.11. View at Publisher | View at Google Scholar | View at Indexing

• Chateau-Degat ML, Dewailly E, Noël M, Valera B, Ferland A, et al. 2010. Hypertension among the Inuit from Nunavik: should we expect an increase because of obesity?. International journal of circumpolar health, 69(4), pp.361-372.

  View at Publisher | View at Google Scholar

• Chateau‐Degat ML, Dannenbaum DA, Egeland GM, Nieboer E, Laouan‐Sidi EA, et al. 2011. A comparison of the metabolic response to abdominal obesity in two Canadian Inuit and First Nations population. Obesity, 19(11), pp.2254-2260.

  View at Publisher | View at Google Scholar

• Poirier P and Rhéaume C, 2008. Obesity and Hypertension. In Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk (pp. 19-25). CRC Press.

  View at Publisher | View at Google Scholar

• Hood RD, Singh P, Hsu F, Güvener T, Carl MA, et al. 2010. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell host & microbe, 7(1), pp.25-37.

  View at Publisher | View at Google Scholar

• Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, et al. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. American journal of respiratory and critical care medicine, 177(9), pp.995-1001.

  View at Publisher | View at Google Scholar

• Lazarevic V, Whiteson K, Huse S, Hernandez D, Farinelli L, et al. 2009. Metagenomic study of the oral microbiota by Illumina high-throughput sequencing. Journal of microbiological methods, 79(3), pp.266-271.

  View at Publisher | View at Google Scholar

• Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, et al. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proceedings of the National Academy of Sciences, 105(39), pp.15070-15075.

  View at Publisher | View at Google Scholar

• Peters BM, Jabra-Rizk MA, Graeme AO, Costerton JW and Shirtliff ME, 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clinical microbiology reviews, 25(1), pp.193-213.

  View at Publisher | View at Google Scholar

• Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, et al. 2008. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog, 4(10), p.e1000184.

  View at Publisher | View at Google Scholar

• Govan JR, Brown AR and Jones AM, 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.

  View at Publisher | View at Google Scholar

• del Fresno C, García-Rio F, Gómez-Piña V, Soares-Schanoski A, Fernández-Ruíz I, et al. 2009. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. The Journal of Immunology, 182(10), pp.6494-6507.

  View at Publisher | View at Google Scholar

• Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, et al. 2011. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PloS one, 6(7), p.e22702.

  View at Publisher | View at Google Scholar

• Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, et al. 2010. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. Journal of Cystic Fibrosis, 9(1), pp.1-16.

  View at Publisher | View at Google Scholar

• Kaunitz AM, Inki P (2012) The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding. Drugs 72: 193-215.

  View at Publisher | View at Google Scholar

• Inki P (2007) Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75: S161-166.

  View at Publisher | View at Google Scholar

• Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Teperi J, Grenman S, et al. (2009) The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial. Acta obstetricia et gynecologica Scandinavica 88: 1389-1396.

  View at Publisher | View at Google Scholar

• Hartmann KE, Jerome RN, Lindegren ML, Potter SA, Shields TC, et al. (2013) Reasons for Exclusion (KQ2).

  View at Publisher | View at Google Scholar

• Have I (2007) About this topic.

  View at Publisher | View at Google Scholar

• Heliövaara-Peippo S (2012) Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia: a 10-year randomized comparative trial.

  View at Publisher | View at Google Scholar

• Hwang S (2008) Imaging of lymphoma of the musculoskeletal system. Radiologic Clinics of North America 46: 379-396.

  View at Publisher | View at Google Scholar

• Asvadi I, Hajipour B, Asvadi A, Asl NA, Roshangar L, et al. (2011) Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. Eur Rev Med Pharmacol Sci 15: 1003-1009.

  View at Publisher | View at Google Scholar

• Green MR, Chamberlain MC (2009) Renal dysfunction during and after high-dose methotrexate. Cancer chemotherapy and pharmacology 63: 599.

  View at Publisher | View at Google Scholar

• Taghizadieh M, Afshari F, Shokri N, Hajipour B (2014) Protective Role of Vitamin E on Methotrexate Induced Renal Injury in Rabbits. Galen Medical Journal 3: 194-199.

  View at Publisher | View at Google Scholar

• Lanke SS, Strom JG, Banga AK (2009) Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques. Critical Reviews™ in Therapeutic Drug Carrier Systems 26.

  View at Publisher | View at Google Scholar

• Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, et al. 2012. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. Journal of bacteriology, 194(17), pp.4709-4717.

  View at Publisher | View at Google Scholar

• Zemanick ET, Sagel SD and Harris JK, 2011. The airway microbiome in cystic fibrosis and implications for treatment. Current opinion in pediatrics, 23(3), pp.319-324.

  View at Publisher | View at Google Scholar

• Rogers GB, Carroll MP and Bruce KD, 2009. Studying bacterial infections through culture-independent approaches. Journal of medical microbiology, 58(11), pp.1401-1418.

  View at Publisher | View at Google Scholar

• Jiang F, Waterfield NR, Yang J, Yang G and Jin Q, 2014. A Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells. Cell host & microbe, 15(5), pp.600-610.

  View at Publisher | View at Google Scholar

• Del Fresno C, Gómez-Piña V, Lores V, Soares-Schanoski A, Fernández-Ruiz I, et al. 2008. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PloS one, 3(7), p.e2667.

  View at Publisher | View at Google Scholar

• Cai Y, Chai D, Wang R, Bai N, Liang BB, et al. 2011. Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. Journal of Antimicrobial Chemotherapy, p.dkr040.

  View at Publisher | View at Google Scholar

• Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, et al. 2013. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PloS one, 8(4), p.e62917.

  View at Publisher | View at Google Scholar

• Pompilio A, Crocetta V, Confalone P, Nicoletti M, Petrucca A, et al. 2010. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC microbiology, 10(1), p.102.

  View at Publisher | View at Google Scholar

• Bittar F and Rolain JM, 2010. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clinical Microbiology and Infection, 16(7), pp.809-820.

  View at Publisher | View at Google Scholar

• Rogers GB, Hoffman LR, Whiteley M, Daniels TW, Carroll MP, et al. 2010. Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends in microbiology, 18(8), pp.357-364.

  View at Publisher | View at Google Scholar

• Arjona Sánchez A, Torres Tordera E, Martínez Cecilia D, Alonso Gómez J, Rufián Peña S (2007) Laparotomía urgente en un caso de paniculitis mesentérica. InAnales de Medicina Interna 24: 566-567.

• Meyboom RH (2009) Metal antagonists. Side Effects of Drugs Annual 31: 399-407.

  View at Publisher | View at Google Scholar

• Kos K, Wilding JP (2012) Diet, exercise and other lifestyle factors. Type 2 Diabetes 25.

  View at Publisher | View at Google Scholar

• Curioni C, Azara C, Capelli J (2011) Rimonabant for Obesity. Anti-Obesity Drug Discovery and Development 1: 131.

  View at Publisher | View at Google Scholar

• Dmochowski RR, Rosenberg MT, Zinner NR, Staskin DR, Sand PK (2010) Extended-release trospium chloride improves quality of life in overactive bladder. Value in Health 13: 251-257.

  View at Publisher | View at Google Scholar

• Zakaria HM, Tantawy SA, Kamel DM, Adel SM, Kassem KA (2009) Fecal Incontinence Responses to Posterior Tibial Nerve Stimulation in Partial Spinal Cord Injured Patients. Bull. Fac. Ph. Th. Cairo Univ 14: 61.

  View at Publisher | View at Google Scholar

Relevant Topics